UNIONDALE, N.Y., Sept. 29, 2016 -- Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) today announced that it intends to offer, subject to market and other conditions, $75 million aggregate principal amount of Convertible Senior Notes due 2019 (the “Notes”) in an underwritten public offering registered under the Securities Act of 1933, as amended. The Company intends to grant the underwriters a 30-day option to purchase up to $11.25 million aggregate principal amount of additional Notes to cover over-allotments, if any.
The Notes will pay interest semiannually and are expected to mature on October 1, 2019, unless earlier converted or repurchased. The Company will not have the right to redeem the Notes prior to maturity. The Notes will be convertible, subject to certain conditions, into cash, shares of the Company’s common stock or a combination thereof, at the Company’s sole election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing the offering.
The Company intends to use the net proceeds from the offering to make investments relating to its business and for general corporate purposes.
J.P. Morgan Securities LLC, JMP Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering.
The offering is being made pursuant to an effective shelf registration statement, including a prospectus and related prospectus supplement, filed by the Company with the Securities and Exchange Commission (“SEC”). These documents may be obtained for free by visiting the SEC’s website at http://www.sec.gov. Alternatively, a copy of the preliminary prospectus supplement and accompanying prospectus related to the offering may be obtained, when available, by contacting J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at [email protected]; or JMP Securities LLC, 600 Montgomery Street, 10th Floor, San Francisco, CA 94111, Attention: Prospectus Department, or by calling (415) 835-3959.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About Arbor Realty Trust, Inc.
Arbor Realty Trust, Inc. (NYSE:ABR) is a real estate investment trust and national direct lender specializing in loan origination and servicing for multifamily, seniors housing, healthcare and other diverse commercial real estate assets. The Company is a Fannie Mae DUS® Multifamily Lender and a Fannie Mae Small Loan lender, a Freddie Mac Program Plus® Seller/Servicer and a Freddie Mac Small Balance Loan Lender, a Fannie Mae and Freddie Mac Seniors Housing Lender, an FHA Multifamily Accelerated Processing (MAP)/LEAN Lender, a HUD-approved LIHTC Lender as well as a CMBS, bridge, mezzanine and preferred equity lender. The Company is externally managed and advised by Arbor Commercial Mortgage, LLC.
Safe Harbor Statement
Certain items in this press release may constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the proposed offering and the anticipated use of the net proceeds from the offering. These statements are based on management’s current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company can give no assurance that its expectations will be attained. Factors that could cause actual results to differ materially from the Company’s expectations include, but are not limited to, risks and uncertainties related to the completion of the public offering on the anticipated terms or at all, market conditions, the satisfaction of customary closing conditions related to the public offering, and other risks detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, Definitive Proxy Statement filed with the SEC on April 22, 2016 and its other reports filed with the SEC. Such forward-looking statements speak only as of the date of this press release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or change in events, conditions, or circumstances on which any such statement is based.
Contacts: Arbor Realty Trust, Inc. Paul Elenio, Chief Financial Officer 516-506-4422 [email protected] Media: Bonnie Habyan, EVP of Marketing 516-506-4615 [email protected] Investors: Joseph Green The Ruth Group 646-536-7013 [email protected]


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



